All Events

Questions Regarding Deflazacort Access and Regulatory Status

November 1, 2016 @ 11:00 am - 12:00 pm PDT

This informational webinar will highlight the regulatory process to date, update the community on Marathon Pharmaceutical’s Expanded Access Program (EAP) for deflazacort and discuss what a potential FDA approval of deflazacort would mean in terms of access to the drug in the United States. Some of those who currently import versions of deflazacort from abroad may have recently received an update from their distributor with initial details, which we will discuss along with steps current deflazacort patients might choose to take to help ensure continued access to U.S. supply of deflazacort if FDA approval is granted.


  • 11:00 am - 12:00 pm


  • Marathon Pharmaceuticals, LLC